1. Home
  2. VTVT
  3. VTVT News

Latest vTv Therapeutics Inc. (VTVT) News on November 24, 2025

VTVT

MT Newswires

5 days ago

BTIG Research Initiates Coverage on vTv Therapeutics With Buy Rating, $40 Price Target

All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy
VTVT

Zacks

13 days ago

All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy

VTVT

Associated Press Finance

17 days ago

VTv Therapeutics: Q3 Earnings Snapshot

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

17 days ago

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
VTVT

GlobeNewswire

a month ago

vTv Therapeutics Announces New Appointments to its Scientific Advisory Board

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
VTVT

GlobeNewswire

5 months ago

vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series

VTVT

MT Newswires

6 months ago

vTv Therapeutics Names Michael Tung as Finance Chief

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
VTVT

GlobeNewswire

6 months ago

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

VTVT

Associated Press Finance

6 months ago

VTv Therapeutics: Q1 Earnings Snapshot

vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

6 months ago

vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update

VTVT

MT Newswires

6 months ago

vTv Therapeutics Resumes Cadisegliatin Testing in Type 1 Diabetes

vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes
VTVT

GlobeNewswire

6 months ago

vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics
VTVT

Zacks

8 months ago

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

VTVT

Associated Press Finance

8 months ago

VTv Therapeutics: Q4 Earnings Snapshot

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

8 months ago

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

FDA removes hold on vTv’s cadisegliatin clinical programme for diabetes
VTVT

Clinical Trials Arena

8 months ago

FDA removes hold on vTv’s cadisegliatin clinical programme for diabetes

vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
VTVT

GuruFocus.com

8 months ago

vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial

FDA Lifts Clinical Hold-vTv Stock Jumps Nearly 28% on Diabetes Drug Progress
VTVT

GuruFocus.com

8 months ago

FDA Lifts Clinical Hold-vTv Stock Jumps Nearly 28% on Diabetes Drug Progress

VTVT

MT Newswires

8 months ago

Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
VTVT

GlobeNewswire

8 months ago

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes

We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate
VTVT

Simply Wall St.

10 months ago

We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER
VTVT

PR Newswire

a year ago

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER

vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference
VTVT

GlobeNewswire

a year ago

vTv Therapeutics to Participate in 7th Annual Evercore HealthCONx Conference

vTv Therapeutics (NASDAQ:VTVT) adds US$9.5m to market cap in the past 7 days, though investors from five years ago are still down 71%
VTVT

Simply Wall St.

a year ago

vTv Therapeutics (NASDAQ:VTVT) adds US$9.5m to market cap in the past 7 days, though investors from five years ago are still down 71%

VTVT

Associated Press Finance

a year ago

VTv Therapeutics: Q3 Earnings Snapshot

vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

a year ago

vTv Therapeutics Announces 2024 Third Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Faces License Agreement Termination
VTVT

TipRanks

a year ago

vTv Therapeutics Faces License Agreement Termination

We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate
VTVT

Simply Wall St.

a year ago

We're Keeping An Eye On vTv Therapeutics' (NASDAQ:VTVT) Cash Burn Rate

VTVT

Associated Press Finance

a year ago

VTv Therapeutics: Q2 Earnings Snapshot

vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

a year ago

vTv Therapeutics Announces 2024 Second Quarter Financial Results and Provides Corporate Update

VTVT

MT Newswires

a year ago

Top Midday Decliners

FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
VTVT

Benzinga

a year ago

FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks

VTVT

MT Newswires

a year ago

Top Premarket Decliners

FDA places vTv Therapeutics’s cadisegliatin programme on clinical hold
VTVT

Clinical Trials Arena

a year ago

FDA places vTv Therapeutics’s cadisegliatin programme on clinical hold

VTVT

MT Newswires

a year ago

vTv Therapeutics' Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold; Shares Sink

vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold
VTVT

GlobeNewswire

a year ago

vTv Therapeutics Announces Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold

VTVT

MT Newswires

a year ago

VTv Therapeutics Announces Screening of First Patient in Trial of Cadisegliatin for Type 1 Diabetes

vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes
VTVT

GlobeNewswire

a year ago

vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes

CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
VTVT

PR Newswire

a year ago

CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING

Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago
VTVT

Simply Wall St.

a year ago

Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago

VTVT

Associated Press Finance

2 years ago

VTv Therapeutics: Q1 Earnings Snapshot

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

2 years ago

vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
VTVT

PR Newswire

2 years ago

CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT

VTVT

Associated Press Finance

2 years ago

VTv Therapeutics: Q4 Earnings Snapshot

vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
VTVT

GlobeNewswire

2 years ago

vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

The Top 3 Healthcare Stocks to Buy on Weakness in 2024
VTVT

InvestorPlace

2 years ago

The Top 3 Healthcare Stocks to Buy on Weakness in 2024

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
VTVT

GlobeNewswire

2 years ago

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes

vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
VTVT

GlobeNewswire

2 years ago

vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
VTVT

GlobeNewswire

2 years ago

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
VTVT

PR Newswire

2 years ago

CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE

VTVT

Argus Research

2 years ago

Daily – Vickers Top Insider Picks for 01/29/2024

Beasley Broadcast Group to Report 2023 Fourth Quarter and Full Year Financial Results, Host Conference Call and Webcast on February 12
VTVT

GlobeNewswire

2 years ago

Beasley Broadcast Group to Report 2023 Fourth Quarter and Full Year Financial Results, Host Conference Call and Webcast on February 12

Yunhong Green CTI Announces Formation of New China Based Subsidiary, Yunhong Technology Industry (Hubei) Co., Ltd
VTVT

ACCESSWIRE

2 years ago

Yunhong Green CTI Announces Formation of New China Based Subsidiary, Yunhong Technology Industry (Hubei) Co., Ltd

5 Top Stocks to Gain as Consumer Confidence Buoys Up
VTVT

Zacks

2 years ago

5 Top Stocks to Gain as Consumer Confidence Buoys Up

Why Fastly (FSLY) Outpaced the Stock Market Today
VTVT

Zacks

2 years ago

Why Fastly (FSLY) Outpaced the Stock Market Today

SU Group Holdings Limited Announces Pricing of Initial Public Offering
VTVT

PR Newswire

2 years ago

SU Group Holdings Limited Announces Pricing of Initial Public Offering

Countdown to HBT Financial (HBT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
VTVT

Zacks

2 years ago

Countdown to HBT Financial (HBT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Why Fastly Stock Popped Today
VTVT

Motley Fool

2 years ago

Why Fastly Stock Popped Today

Invitae sells reproductive health assets amid liquidity concerns
VTVT

MedTech Dive

2 years ago

Invitae sells reproductive health assets amid liquidity concerns

Via Renewables, Inc. Announces Dividend on Preferred Stock
VTVT

ACCESSWIRE

2 years ago

Via Renewables, Inc. Announces Dividend on Preferred Stock

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model
VTVT

Business Wire

2 years ago

Vintage Wine Estates Restructures Organization, Initiates Cost Cuts and Simplifies Business Model

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers
VTVT

GlobeNewswire

2 years ago

KULR Secures Exclusive Global License for NASA’s Battery Safety Technology to Service World’s Largest OEM Customers

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
VTVT

GlobeNewswire

2 years ago

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

VTVT

GlobeNewswire

2 years ago

Proximic by Comscore Releases Findings from 2024 State of Programmatic Report

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana
VTVT

ACCESSWIRE

2 years ago

American Resources Corporation's ReElement Technologies Engages Law Firm Alexander & Partner for Formation of ReElement Ghana

Sunrise New Energy Files for China Patent Award, the Highest Honor in Intellectual Property Rights
VTVT

GlobeNewswire

2 years ago

Sunrise New Energy Files for China Patent Award, the Highest Honor in Intellectual Property Rights

VTVT

Business Wire

2 years ago

Xos and ElectraMeccanica Announce Proposed Combination to Accelerate Xos’ Leadership Position in Manufacturing Commercial Electric Vehicles for Major U.S. Fleet Customers

Should Value Investors Buy OP Bancorp (OPBK) Stock?
VTVT

Zacks

2 years ago

Should Value Investors Buy OP Bancorp (OPBK) Stock?

American Resources Corporation’s ReElement Technologies Executes MOU for Initial Offtake of LFP Black Mass with Duesenfeld GmbH
VTVT

ACCESSWIRE

2 years ago

American Resources Corporation’s ReElement Technologies Executes MOU for Initial Offtake of LFP Black Mass with Duesenfeld GmbH

UPDATE — HBT Financial, Inc. to Announce Fourth Quarter 2023 Financial Results on January 24, 2024
VTVT

GlobeNewswire

2 years ago

UPDATE — HBT Financial, Inc. to Announce Fourth Quarter 2023 Financial Results on January 24, 2024

comScore (SCOR) Surges 7.1%: Is This an Indication of Further Gains?
VTVT

Zacks

2 years ago

comScore (SCOR) Surges 7.1%: Is This an Indication of Further Gains?

The Zacks Analyst Blog Highlights JAKKS Pacific, Hooker Furniture, Netflix, Skillz and Acushnet
VTVT

Zacks

2 years ago

The Zacks Analyst Blog Highlights JAKKS Pacific, Hooker Furniture, Netflix, Skillz and Acushnet

Creative Realities to Debut as Exhibitors at NRF 2024: Retail’s Big Show
VTVT

GlobeNewswire

2 years ago

Creative Realities to Debut as Exhibitors at NRF 2024: Retail’s Big Show

Hooker Furnishings to Present at the Water Tower Research Furniture/Furnishings Virtual Conference January 17
VTVT

GlobeNewswire

2 years ago

Hooker Furnishings to Present at the Water Tower Research Furniture/Furnishings Virtual Conference January 17

EPOW’s CEO Purchased 245,000 Shares of the Company’s Ordinary Shares
VTVT

GlobeNewswire

2 years ago

EPOW’s CEO Purchased 245,000 Shares of the Company’s Ordinary Shares

DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
VTVT

Business Wire

2 years ago

DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)

Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs
VTVT

Zacks

2 years ago

Novo Nordisk (NVO) Up on $1.1B Research Deals With 2 Biotechs

Should Value Investors Buy First Horizon (FHN) Stock?
VTVT

Zacks

2 years ago

Should Value Investors Buy First Horizon (FHN) Stock?

The Best-Performing REITs Of 2023
VTVT

Benzinga

2 years ago

The Best-Performing REITs Of 2023

With EPS Growth And More, Optex Systems Holdings (NASDAQ:OPXS) Makes An Interesting Case
VTVT

Simply Wall St.

2 years ago

With EPS Growth And More, Optex Systems Holdings (NASDAQ:OPXS) Makes An Interesting Case

Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook
VTVT

Simply Wall St.

2 years ago

Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
VTVT

GlobeNewswire

2 years ago

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company
VTVT

Simply Wall St.

2 years ago

Aadi Bioscience, Inc. (NASDAQ:AADI) is definitely on the radar of institutional investors who own 39% of the company

Fathom Realty Welcomes Divine Properties Group, Expanding its Network of Exceptional Agents in California
VTVT

PR Newswire

2 years ago

Fathom Realty Welcomes Divine Properties Group, Expanding its Network of Exceptional Agents in California

Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting
VTVT

Business Wire

2 years ago

Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting

OFS Credit Company Announces Financial Results for the Fourth Fiscal Quarter 2023
VTVT

Business Wire

2 years ago

OFS Credit Company Announces Financial Results for the Fourth Fiscal Quarter 2023

VTVT

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Delta Apparel Inc Earnings Call

Delta Apparel, Inc. (AMEX:DLA) Q4 2023 Earnings Call Transcript
VTVT

Insider Monkey

2 years ago

Delta Apparel, Inc. (AMEX:DLA) Q4 2023 Earnings Call Transcript

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock
VTVT

Zacks

2 years ago

What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock

Imperial Petroleum Inc. Announces Repurchase of 3.2 Million Warrants
VTVT

GlobeNewswire

2 years ago

Imperial Petroleum Inc. Announces Repurchase of 3.2 Million Warrants

VTVT

GlobeNewswire

2 years ago

Digihost Provides November 2023 Production Update

Stran & Company to Present at the Investor Summit on December 7th
VTVT

GlobeNewswire

2 years ago

Stran & Company to Present at the Investor Summit on December 7th

Xos Announces 1-for-30 Reverse Stock Split
VTVT

GlobeNewswire

2 years ago

Xos Announces 1-for-30 Reverse Stock Split

TrueBlue to Participate in the Sidoti Virtual Investor Conference
VTVT

Business Wire

2 years ago

TrueBlue to Participate in the Sidoti Virtual Investor Conference

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
VTVT

GlobeNewswire

2 years ago

Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024
VTVT

Business Wire

2 years ago

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024

Shareholders in SuRo Capital (NASDAQ:SSSS) are in the red if they invested three years ago
VTVT

Simply Wall St.

2 years ago

Shareholders in SuRo Capital (NASDAQ:SSSS) are in the red if they invested three years ago

First US Bancshares (NASDAQ:FUSB) Has Affirmed Its Dividend Of $0.05
VTVT

Simply Wall St.

2 years ago

First US Bancshares (NASDAQ:FUSB) Has Affirmed Its Dividend Of $0.05

TrueBlue (NYSE:TBI) shareholders have endured a 44% loss from investing in the stock five years ago
VTVT

Simply Wall St.

2 years ago

TrueBlue (NYSE:TBI) shareholders have endured a 44% loss from investing in the stock five years ago

First US Bancshares, Inc. Announces Extension of Share Repurchase Program
VTVT

PR Newswire

2 years ago

First US Bancshares, Inc. Announces Extension of Share Repurchase Program

Share on Social Networks: